Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis

10Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction: An association between the vitamin D receptor (V. DR) GAT haplotype and coronary artery disease (CAD) in type-2 diabetes has recently been described. Since cardiovascular mortality in rheumatoid arthritis (RA) is comparable to that observed for patients with type-2 diabetes, we aimed to determine if V. DR GAT haplotype is also associated with atherosclerotic disease in RA. Material and Methods: 591 Northern Spanish RA patients were genotyped for 4 VDR polymorphisms (rs731236 A/G; rs7975232 A/C; rs1544410C/T; rs2228570 G/A). Atherosclerotic disease was established by the presence of carotid plaques in carotid ultrasound. Results: VDR rs7975232 AA genotype was increased in RA patients with plaques (p = 0.045, OR = 1.46 [1.01-2.18]). More importantly, the frequency of carotid plaques was significantly increased in RA patients who carried the GATG haplotype (p = 0.009, OR = 1.56 [1.09-2.42]). Conclusion: Our results suggest a potential VDR GATG haplotype association with atherosclerotic disease in RA patients.

Cite

CITATION STYLE

APA

López-Mejías, R., Genre, F., Remuzgo-Martínez, S., Robledo, G., Llorca, J., Corrales, A., … González-Gay, M. A. (2016). Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis. Atherosclerosis, 245, 139–142. https://doi.org/10.1016/j.atherosclerosis.2015.12.011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free